Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Briacell Therapeutics Corp fell by 19.79m. Cash Flow from Financing totalled 3.95m or -- of revenues. In addition the company used 23.74m for operations while cash used for investing totalled .
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.5065 |
---|---|
Tangible book value per share | -0.5237 |
More ▼
Balance sheet in USDView more
Current ratio | 0.8183 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼